The non-innocent nature of graphene oxide as a theranostic platform for biomedical applications and its reactivity towards metal-based anticancer drugs

Audrey Mokdad, Konstantinos Dimos, Giorgio Zoppellaro, Jiří Tuček, Jason A. Perman, Ondřéj Malina, K. Kristoffer Andersson, K. K. R. Datta, Jens P. Froning, Radek Zbořil

RSC Advances · 2015 · 12 citations · 66 references

Concepts

Abstract

The self-assembly process of a mononuclear iron(<sc>ii</sc>) complex as anticancer agent with graphene oxide (GO) unveils the ability of GO to oxidize the metal drug.

References

66